InvestorsObserver is giving FibroGen Inc (FGEN) an Analyst Rating Rank of 2, meaning FGEN is ranked higher by analysts than 2% of stocks. The average price target for FGEN is $1.033 and analyst’s rate the stock as a Hold.
Wall Street analysts are rating FGEN a Hold today. Find out what this means to you and get the rest of the rankings on FGEN!
Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. Analysts understand how bad weather in one part of the world can disrupt supply chains, or disrupt shopping patterns. This lets traders make decisions before a quarterly report that could be worse than expected.
InvestorsObserver aggregates the ratings of all the analysts covering a given stock, takes the average of those ratings and then percentile ranks the averages. That provides a level of granularity that is significantly better than just the three levels provided by traditional buy/hold/sell ratings.
What's Happening With FibroGen Inc Stock Today?
FibroGen Inc (FGEN) stock has gained 6.36% while the S&P 500 is down -0.22% as of 1:41 PM on Thursday, Nov 30. FGEN is higher by $0.03 from the previous closing price of $0.50 on volume of 1,365,647 shares. Over the past year the S&P 500 has gained 11.29% while FGEN is down -96.31%. FGEN lost -$3.06 per share the over the last 12 months.
Click Here to get the full Stock Report for FibroGen Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
